Applied Genetic Technologies Corporation (AGTC) financial statements (2022 and earlier)

Company profile

Business Address 14193 NW 119TH TERRACE
ALACHUA, FL 32615
State of Incorp. DE
Fiscal Year End June 30
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:53818210512799
Cash and cash equivalents193827313129
Short-term investments344255749670
Other undisclosed cash, cash equivalents, and short-term investments000   
Receivables  0001
Other undisclosed current assets222433
Total current assets:558384109130103
Noncurrent Assets
Finance lease, right-of-use asset00
Operating lease, right-of-use asset33
Property, plant and equipment444533
Long-term investments and receivables88 21274
Long-term investments88 21274
Intangible assets, net (including goodwill)111111
Intangible assets, net (excluding goodwill)111111
Other noncurrent assets001100
Other undisclosed noncurrent assets  2 2 
Total noncurrent assets:1717891878
TOTAL ASSETS:7210092119148181
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities254343
Accounts payable211111
Employee-related liabilities 32222
Taxes payable    2 
Debt00    
Deferred revenue and credits621 
Other undisclosed current liabilities12865352
Total current liabilities:14139142855
Noncurrent Liabilities
Long-term debt and lease obligation44    
Finance lease, liability00
Operating lease, liability44
Liabilities, other than long-term debt3345417
Deferred revenue and credits1417
Other liabilities3344  
Other undisclosed noncurrent liabilities1010    
Total noncurrent liabilities:161645417
Total liabilities:302914193372
Stockholders' equity
Stockholders' equity attributable to parent42717999115109
Common stock000000
Treasury stock, value(0)(0)(0)(0)  
Additional paid in capital254253214210205199
Accumulated deficit(212)(181)(136)(111)(90)(90)
Total stockholders' equity:42717999115109
TOTAL LIABILITIES AND EQUITY:7210092119148181

Income statement (P&L) ($ in millions)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Gross profit: 242243947
Operating expenses(56)(49)(46)(47)(38)(49)
Operating income (loss):(56)(47)(4)(22)2(2)
Nonoperating income (expense)(0)12111
Investment income, nonoperating012111
Other nonoperating income (expense)0(0)0(0)(0)(0)
Interest and debt expense(1)(0)    
Other undisclosed income from continuing operations before equity method investments, income taxes10    
Income (loss) from continuing operations before equity method investments, income taxes:(56)(46)(2)(21)3(1)
Loss from equity method investments(0)(0)(0)   
Income (loss) from continuing operations before income taxes:(56)(46)(2)(21)3(1)
Income tax expense(0)(0)(0)(0)(2) 
Income (loss) before gain (loss) on sale of properties:(57)(46)(2)(21)0(1)
Other undisclosed net loss   (0)  
Net income (loss) available to common stockholders, diluted:(57)(46)(2)(21)0(1)

Comprehensive Income ($ in millions)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Net income (loss):(57)(46)(2)(21)0(1)
Comprehensive income (loss), net of tax, attributable to parent:(57)(46)(2)(21)0(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: